Ontology highlight
ABSTRACT: Importance
Medicaid enrolls a disproportionate share of US adults with hepatitis C virus (HCV), and most receive Medicaid benefits through managed care organizations (MCOs). Medicaid MCOs often impose stricter requirements to access HCV medications than traditional fee-for-service Medicaid, which may inhibit use. Though Medicaid MCOs generally cover prescription drugs, several states have carved out direct-acting antiviral HCV medications from MCO coverage and opted to cover them under fee-for-service. Whether these carve outs were associated with changes in medication use is unknown.Objective
To examine the association between Medicaid-covered HCV medication fills and carve outs of these medications from MCO coverage.Design setting and participants
This cross-secti
SUBMITTER: Auty SG
PROVIDER: S-EPMC8796891 | biostudies-literature | 2021 Aug
REPOSITORIES: biostudies-literature